Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Aim    To identify predictors and develop a model for prognosis of left ventricular (LV) ejection fraction (EF) 12 months after ST-segment elevation myocardial infarction (STEMI) on electrocardiogram (ECG).Material and methods    This was a prospective registry study of patients admitted within 24 h of STEMI. Concentrations of soluble suppression of tumorigenicity 2, proprotein convertase subtilisin/kexin type 9, N-terminal pro-B-type natriuretic peptide (NTproBNP), high-sensitivity troponin I (TnI), and C-reactive protein were measured. LVEF was determined using the Simpson method at one, 10-12 days, and 12 months after STEMI. The study included 138 patients; after 12 months, LVEF was determined in 112 patients. The patients were divided into groups based on their LVEF: with preserved EF (pLVEF), LVEF ≥50% (n=51); moderately reduced EF (mrLVFE), LVEF 41-49% (n=40); and reduced EF (rLVEF), LVEF ≤40% (n=11).Results     A model for predicting LVEF 12 months after STEMI was constructed using the ordinal regression. The model sensitivity was 88.2% for predicting pLVEF, 71.8% for predicting mrLVEF, and 72.5% for predicting rLVEF. The model specificity was 59.1%. The factors determining LVEF in STEMI patients after 12 months included the formation of postinfarction LV aneurysm, LVEF on days 10-12 after STEMI, the magnitude in mm of ST segment elevation on the ECG upon admission, and the TnI concentration on the first day of STEMI.Conclusions    The obtained model for predicting LVEF 12 months after STEMI allows prognosing LVEF in all its ranges with a sensitivity of more than 70%.

Download full-text PDF

Source
http://dx.doi.org/10.18087/cardio.2025.4.n2823DOI Listing

Publication Analysis

Top Keywords

months stemi
12
lvef
11
left ventricular
8
ventricular ejection
8
ejection fraction
8
fraction months
8
months st-segment
8
st-segment elevation
8
elevation myocardial
8
lvef determined
8

Similar Publications

Aim        To compare the results of primary percutaneous coronary intervention (PCI) for non-ST-segment elevation acute coronary syndrome (NSTE-ACS) in patients who recently recovered from COVID-19 with those not previously infected with SARS-CoV-2; to establish prognostic criteria for PCI complications, including stent thrombosis and restenosis (ST and SR) and progression of ischemic heart disease, and to determine ways to prevent them.Material and methods         In 2021, middle-aged patients admitted to the Baku Central Clinical Hospital with a diagnosis of acute coronary syndrome who underwent urgent myocardial revascularization using percutaneous balloon angioplasty of the occluded coronary artery (CA) with implantation of a second-generation intracoronary drug-eluting stent were divided into two observation groups: the main group of 123 patients who had COVID-19 in the previous 6 months, and the control group of 112 patients who were not previously infected with SARS-CoV-2. The immediate results of PCI were assessed according to the TIMI scale; complications were assessed both clinically, by the incidence of severe complications (major adverse cardiovascular events, MACE), and angiographically, by the incidence of early and late ST and SR, and de novo stenosis that developed during the two-year observation period.

View Article and Find Full Text PDF

Background: ST-segment elevation myocardial infarction (STEMI) demands aggressive and rapid medical intervention. Delays in Door-to-balloon time (DTB) of more than 90 min cause progressive damage to the cardiac tissue and require immediate medical intervention, including percutaneous coronary intervention (PCI). Nurses and doctors in STEMI management face several challenges that result in a delay in DTB time.

View Article and Find Full Text PDF

In this review, we aimed to evaluate Sonothrombolysis when combined with primary percutaneous coronary intervention (pPCI) in STEMI patients with regard to improving cardiac function and clinical outcomes. This study primarily assesses short-term efficacy outcomes, while long-term impacts, such as mortality, were not evaluated. Following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, we searched four electronic databases (PubMed, Scopus, Cochrane Library, and Web of Science) to identify eligible studies reported up to November 2024.

View Article and Find Full Text PDF

Background: Stroke volume is an established echocardiographic marker but has not been widely studied in patients with ST-segment elevation myocardial infarction (STEMI). We aimed to evaluate stroke volume in a cohort of uncomplicated anterior STEMI and to assess its prognostic role in those with severe left ventricle (LV) systolic dysfunction.

Methods And Results: This is a single-centre retrospective analysis of consecutive patients presenting with anterior STEMI who underwent uncomplicated primary percutaneous coronary intervention.

View Article and Find Full Text PDF

We describe a case of a woman in her 70s who presented with acute chest pain and ST-segment elevation on ECG. Multimodality cardiac imaging confirmed Takotsubo cardiomyopathy alongside a pedunculated left ventricular mass, presumed to be a thrombus, with suspected embolisation to the left anterior descending artery, triggering an acute myocardial infarction. She received guideline-directed medical therapy for heart failure and anticoagulation for the thrombus.

View Article and Find Full Text PDF